SLC7A11与Ki-67在喉鳞状细胞癌中的表达及临床意义

doi:01.3969/j.issn.1006-6233.2020.12.010

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1385 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To observe the expression of SLC7A11 and Ki-67 in laryngeal carcinoma, and to explore its role in the occurrence and progression of laryngeal carcinoma. Methods: The relative expression of SLC7A11 and Ki-67 in 117 cases of laryngeal carcinomas tissues ( laryngeal carcinoma group) and 65 cases of vocal polyps ( control group) was detected by immunohistochemical SP method. The relationship between the expression and the clinicopathological features of laryngeal carcinoma was analyzed. Chi-square test was used to analyze the relationship between SLC7A11 and Ki-67 expression and prognosis and recurrence of patients with laryngeal carcinoma. Results: The positive expression levels of and SLC7A11 and Ki-67 were higher in the laryngeal carcinoma group than in the control group ( χ² = 9.630、8.006,both P＜0.05). High expression of SLC7A11 and Ki-67 was associated with high clinical stage of laryngeal cancer(P＜0.05).And it was not related to the survival of patients with laryngeal cancer. Conclusion: The high expression of SLC7A11 and Ki-67 in the laryngeal carcinoma are related to the disease progression and postoperative recurrence,and it is important for the prognosis of patients.

Key words： Laryngeal neoplasms SLC7A11 Ki-67 Prognosis Recurrence

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://www.hbyxzzs.cn/EN/01.3969/j.issn.1006-6233.2020.12.010 OR http://www.hbyxzzs.cn/EN/Y2020/V26/I12/1978

[1] 中华耳鼻咽喉头颈外科杂志编辑委员会头颈外科组,中华医学会耳鼻咽喉头颈外科学会头颈学组.喉癌外科手术及综合治疗专家共识[J].中华耳鼻咽喉头颈外科杂志,2014,49(8):620626~620629.
[2] 张春明,高伟,董蜀斌,等.Bax与PHF20蛋白在喉鳞状细胞癌中的表达及临床意义[J].临床耳鼻咽喉头颈外科杂志,2015,29(19):1701~1705.
[3] Polewski MD,Reveron -Thornton RF,Cherryholmes GA,et al.SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties [J].Stem Cells Dev, 2017,26(17):1236~1246.
[4] Ji X,Qian J,Rahman SMJ,et al.xCT (SLC7A11) -mediated metabolic reprogramming promotes non-small cell lung cancer progression[J].Oncogene,2018,37(36):5007~5019.
[5] Ding J,Xie M,Lian Y,et al. Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2,LSD1 in colorectal cancer[J]. Oncogenesis,2017, 6( 1) :e288~292.
[6] Tuomi L,Kjarlsson Tkjohansson M,et al.Health-related quality of life and voice following radiotherapy for laryngeal cancer-a comparison between glottic and supraglottic tumours[J]. Acta Oncol,2015,54(18):73~79.
[7] Polewski MD,Reveron -Thornton RF,Cherryholmes GA,et al.SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties [J].Stem Cells Dev, 2017,26(17):1236~1246.
[8] Polewski MD,Reveron -Thornton RF,Cherryholmes GA,et al.SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties [J].Stem Cells Dev, 2017,26(17):1236~1246.
[9] Ji X,Qian J,Rahman SMJ,et al.xCT (SLC7A11) -mediated metabolic reprogramming promotes non-small cell lung cancer progression[J].Oncogene,2018,37(36):5007~5019.
[10] Robert SM, Buckingham SC, Campbell SL, et al.SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma[J]. Sci Transl Med,2015,2(7): 289~305.
[11] Guo W, Zhao Y, Zhang Z, et al.Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma[J]. Cancer Lett,2011,3(12):55~61.
[12] Wang SJ,Gu W.To be, or not to be: functional dilemma of P53 metabolic regulation[J]. Curr Opin Oncol,2014,26(4):78~85.
[13] Bieging KT,Attardi LD.Deconstructing P53 transcriptional networks in tumor suppression[J].Trends Cell Biol,2012,2(2):97~106.